First Time Loading...

Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.38 CHF 0.9%
Updated: May 7, 2024

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 7.38 CHF with a low forecast of 3.03 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
3.03 CHF
10% Downside
Average
Price Target
7.38 CHF
118% Upside
Highest
Price Target
15.75 CHF
366% Upside
Molecular Partners AG Competitors:
Price Targets
002038
Beijing SL Pharmaceutical Co Ltd
384% Upside
603387
Getein Biotech Inc
280% Upside
NKTX
Nkarta Inc
177% Upside
VYGR
Voyager Therapeutics Inc
102% Upside
358570
GI Innovation Inc
79% Upside
87S
Roivant Sciences Ltd
43% Upside
SWTX
SpringWorks Therapeutics Inc
46% Upside
PROB
Probi AB
54% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 43%.

-16%
Past Growth
43%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
7.38 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 7.38 CHF with a low forecast of 3.03 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
43%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 43%.